Case Analysis: Dr. Yash Pal Sahi v. Delhi Administration

Case Details

Case name: Dr. Yash Pal Sahi v. Delhi Administration
Court: Supreme Court of India
Judges: P.B. Gajendragadkar, K.C. Das Gupta
Date of decision: 29 November 1963
Citation / citations: 1964 AIR 784; 1964 SCR (5) 582
Case number / petition number: Criminal Appeal No. 157 of 1962; Criminal Revision Application No. 281-D of 1961
Neutral citation: 1964 SCR (5) 582
Proceeding type: Criminal Appeal
Source court or forum: Supreme Court of India

Source Judgment: Read judgment

Factual and Procedural Background

Dr. Yash Pal Sahi and his wife, Dr. Susheela Sahi, owned a homoeopathic hospital at Jangpura, New Delhi, and published the journal “Homoeopathic Doctor.” On 15 May 1958, a person named Misri Singh wrote to Dr. Sahi requesting copies of the journal from 15 January 1958 onward and a list of medicines, offering to pay the price. Acting on this request, Dr. Sahi dispatched a packet on 24 May 1958 that contained copies of the journal (Exhibits P‑1 to P‑6) and a list of medicines titled “Fehrist‑i‑Mujarabat” (Exhibit P‑7). The packet was opened by Misri Singh in the presence of Mr Seth, an officer of the Delhi Administration, and other witnesses.

The prosecution alleged that by sending the packet the appellant had committed an offence under section 3 read with section 7 of the Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954. The complaint against Dr. Susheela Sahi was withdrawn, leaving the case against Dr. Yash Pal Sahi alone.

At trial, the learned Magistrate heard evidence of Mr Seth, Misri Singh and Dr Anant Parkash, and the appellant admitted that he had sent the packet. The Magistrate held the appellant guilty of the offence and imposed a fine of Rs 1,000. On appeal, the Additional Sessions Judge affirmed the conviction but reduced the fine to Rs 500, observing that Exhibit P‑7 listed medicines and advertised their effects and prices, thereby falling within the mischief of the Act.

The appellant then filed a revisional application before the Punjab High Court, contending that section 14(1)(c) exempted his conduct. The High Court rejected this argument and dismissed the revision. By special leave, the appellant appealed to the Supreme Court of India (Criminal Appeal No. 157 of 1962). The appeal was heard by a two‑judge bench of Justices P.B. Gajendragadkar and K.C. Das Gupta.

Issues, Contentions and Controversy

The Court was required to determine:

1. Whether the appellant was guilty of an offence punishable under section 3 read with section 7 of the Act, considering that Exhibit P‑7 described medicines for menstrual disorders and venereal diseases.

2. Whether the exemption provided by section 14(1)(c) applied, i.e., whether the advertisement had been sent “confidentially in the prescribed manner” to a person who was a registered medical practitioner, a wholesale or retail chemist, or a hospital/laboratory.

3. Whether compliance with Rule 6 of the Rules framed under the Act—specifically the requirement that the document bear a conspicuous statement in indelible ink—was sufficient to invoke the exemption.

4. Whether the fine should remain at Rs 1,000 or be retained at the reduced amount of Rs 500.

The appellant contended that the packet had been sent confidentially to a person he believed to be a registered medical practitioner, that the indelible‑ink notice satisfied Rule 6, and that the exemption therefore barred liability. The State argued that the recipient, Misri Singh, was a clerk and not a registered practitioner, that the statutory conditions of section 14(1)(c) were not met, and that the conviction and fine were proper.

Statutory Framework and Legal Principles

The Court referred to the Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954. The relevant provisions were:

Section 2(d) – defined “taking any part in the publication of any advertisement” to include both printing and sending of the advertisement within the territory to which the Act applied; the definition was held to be inclusive.

Section 3(c) and 3(d) – prohibited any person from taking part in the publication of an advertisement that suggested the use of a drug for the correction of menstrual disorders or for the diagnosis, cure, mitigation, treatment or prevention of venereal disease.

Section 7 – prescribed imprisonment, fine or both for a first conviction of an offence under section 3.

Section 14(1)(c) – exempted from the operation of the Act any advertisement sent confidentially in the prescribed manner only to a registered medical practitioner, a wholesale or retail chemist, or a hospital/laboratory.

Rule 6 – required that such documents be sent by post to a registered medical practitioner or a wholesale/retail chemist and bear, in indelible ink, a conspicuous statement that they were “for the use only of registered medical practitioners or a hospital or a laboratory.”

The legal test applied by the Court was two‑fold: (i) ascertain whether the material fell within the prohibited categories of section 3, and (ii) determine whether the conditions of the exemption in section 14(1)(c) and Rule 6 were satisfied. The burden of proving the recipient’s status rested on the appellant.

Court’s Reasoning and Application of Law

The Court first held that the inclusive definition in section 2(d) meant that the act of sending Exhibit P‑7 to Misri Singh constituted “publication” of an advertisement within the meaning of the Act. It then found that Exhibit P‑7 described medicines for menstrual disorders and venereal diseases, thereby falling squarely within the prohibited categories of sections 3(c) and 3(d). Consequently, the appellant had taken part in the publication of a prohibited advertisement, attracting liability under section 7.

Turning to the exemption, the Court examined the requirements of section 14(1)(c) and Rule 6. It observed that compliance with the indelible‑ink notice satisfied only one condition of Rule 6. The second condition—sending the advertisement to a person who actually was a registered medical practitioner, a wholesale or retail chemist, or a hospital/laboratory—was not fulfilled because Misri Singh was a clerk employed by Dr Anant Parkash and not a registered practitioner. The Court emphasized that the appellant had failed to produce any evidence of an enquiry into the recipient’s status or of a bona‑fide belief that the recipient satisfied the statutory definition. Accordingly, the exemption could not be invoked.

Having established that the statutory conditions of the exemption were unmet, the Court affirmed the conviction. Regarding sentencing, the Court considered the discretion exercised by the Additional Sessions Judge and held that the reduction of the fine from Rs 1,000 to Rs 500 was appropriate and within the bounds of judicial discretion.

Final Relief and Conclusion

The Supreme Court dismissed the appeal, upheld the conviction of Dr. Yash Pal Sahi under section 3 read with section 7 of the Drugs and Magic Remedies (Objectionable Advertisement) Act, and confirmed the reduced fine of Rs 500 imposed by the Additional Sessions Judge. No relief was granted to the appellant.